SCAI and CRT Join Forces: A Powerful Alliance for Interventional Cardiology Innovation and Training
The Society for Cardiovascular Angiography & Interventions (SCAI) and Cardiovascular Research Technologies (CRT) have announced a groundbreaking partnership, uniting their expertise and resources to revolutionize the field of interventional cardiology. This collaboration aims to enhance education, advocacy, and research, ultimately improving patient outcomes.
In this joint venture, CRT offers SCAI members exclusive discounted registration for the upcoming CRT 2026 event, providing a unique opportunity for members to access high-quality education. SCAI, in turn, will organize a 'Day on the Hill' legislative event in Washington, D.C., leveraging its advocacy skills to amplify the voice of interventional cardiologists in policy discussions.
Looking ahead, SCAI and CRT will explore collaborative research initiatives, including the development of innovative registries and clinical trial programs. This partnership will be steered by the SCAI-CRT Task Force, a dedicated group of representatives from both organizations, who will identify and coordinate collaborative projects.
SCAI will also establish a working group to evaluate and support research proposals, ensuring the highest standards of scientific inquiry. CRT will contribute core lab services, and together, they will secure external funding to drive their joint efforts forward.
This collaboration is a testament to the power of unity in the medical field. By combining their strengths, SCAI and CRT aim to:
- Engage Physicians: Create platforms and programs that bring interventional cardiologists together, fostering a community of learning and innovation.
- Foster Innovation: Drive the development of cutting-edge technologies and treatment approaches, pushing the boundaries of what's possible in interventional cardiology.
- Address Clinical Challenges: Collaborate on research projects that tackle real-world clinical issues, ensuring that patients receive the best possible care.
"Our partnership symbolizes a shared vision for the future of interventional cardiology," said J. Dawn Abbott, MD, MSCAI, chair of the SCAI-CRT Partnership Task Force and president-elect of SCAI. "Together, we will create pathways for physician engagement, accelerate research, and build programs that address the ever-evolving challenges in our field."
"Through this collaboration, CRT and SCAI are expanding their collective impact," added Ron Waksman, MD, MSCAI, chair of the CRT meeting. "We're connecting clinical science, advocacy, and education, bringing together experts from across cardiovascular medicine. Our goal is to strengthen the research pipeline, inspire the next generation of interventionalists, and ensure that patients worldwide benefit from the rapid advancements in interventional labs."
This partnership is a significant step forward, promising a brighter future for interventional cardiology. As SCAI and CRT work together, they will undoubtedly unlock new possibilities, driving innovation and improving patient care.
